Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
Clinical trial NCT00004889 · COMPLETED
Trial details
- NCT number
- NCT00004889
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-01
- Primary completion
- 2002-01-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.